Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Hepatic steatosis is a major feature associated with NAFLD (non-alcoholic fatty liver disease). The aims of the present study were to assess the levels of PUFA (polyunsaturated fatty acids) in liver total lipids, triacylglycerols (triglycerides) and phospholipids of NAFLD patients in relation to those in adipose tissue and hepatic indexes related to oxidative stress as factors contributing to hepatic steatosis. Eleven control subjects and 19 patients with NAFLD were studied. Analysis of liver and abdominal adipose tissue fatty acids was carried out by GLC. The liver content of protein carbonyl groups and malondialdehyde were taken as indexes related to oxidative stress. NAFLD patients had a depletion in LCPUFA (long-chain PUFA) of the n-6 and n-3 series in liver triacylglycerols, with decreased 20:4,n-6/18:2,n-6 and (20:5,n-3+22:6,n-3)/18:3,n-3 ratios, whereas liver phospholipids contained higher n-6 and lower n-3 LCPUFA. These findings were accompanied by an enhancement of (i) n-6/n-3 ratio in liver and adipose tissue, (ii) 18:1,n-9 trans levels in adipose tissue, and (iii) hepatic lipid peroxidation and protein oxidation indexes. It is concluded that a marked enhancement in LCPUFA n-6/n-3 ratio occurs in the liver of NAFLD patients, a condition that may favour lipid synthesis over oxidation and secretion, thereby leading to steatosis. Depletion of hepatic LCPUFA may result from both defective desaturation of PUFA, due to inadequate intake of precursors, such as 18:3,n-3, and higher intake of the 18:1,n-9 trans isomer leading to desaturase inhibition, and from an increased peroxidation of LCPUFA due to oxidative stress.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The first lipidomic studies showed that individuals with moderate96 or severe97 obesity and MASLD had phospholipids rich in monounsaturated fatty acids (palmitoleic, oleic acid) and long-chain PUFAs (n-6:n-3 ratio, and n-6) compared with controls.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [97]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
Ohkawa, H., Ohishi, N., & Yagi, K. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90738-3 · Cited by 29,297
[38] Oxidative damage to proteins: Spectrophotometric method for carbonyl assay
Reznick, A. Z., & Packer, L. (1994) · Methods in Enzymology · doi:10.1016/s0076-6879(94)33041-7 · Cited by 2,452
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
Biochemistry of Oxidative Stress
Sies, H. (1986) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198610581 · Cited by 1,306
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
Cytochrome P-4502E1: its physiological and pathological role
Lieber, C. S. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.2.517 · Cited by 889
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
Weltman, M. D., Farrell, G. C., Hall, P., Ingelman-Sundberg, M., & Liddle, C. (1998) · Hepatology · doi:10.1002/hep.510270121 · Cited by 614
Burdge, G. C., Jones, A. E., & Wootton, S. A. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2002662 · Cited by 598
Cited by
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
“Humans (16) and mice (17) with hepatic steatosis accumulate excess oleic acid, the end-product of de novo fatty acid synthesis.”
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955
Health Implications of High Dietary Omega-6 Polyunsaturated Fatty Acids
Patterson, E., Wall, R., Fitzgerald, G. F., Ross, R. P., & Stanton, C. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/539426 · Cited by 883
Triggering and resolution of inflammation in NASH
Schuster, S., Cabrera, D., Arrese, M., & Feldstein, A. E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0009-6 · Cited by 943
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Tiniakos, D. G., Vos, M. B., & Brunt, E. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102132 · Cited by 870
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J.-M., & Lustig, R. H. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.41 · Cited by 771
Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research
Anstee, Q. M., & Goldin, R. D. (2006) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2006.00465.x · Cited by 714
The plasma lipidomic signature of nonalcoholic steatohepatitis
Puri, P., Wiest, M. M., Cheung, O., Mirshahi, F., Sargeant, C., Min, H., Contos, M. J., Sterling, R. K., Fuchs, M., Zhou, H., et al. (2009) · Hepatology · doi:10.1002/hep.23229 · Cited by 655
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
Hardy, T., Oakley, F., Anstee, Q. M., & Day, C. P. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044224 · Cited by 611
From NAFLD to NASH to cirrhosis—new insights into disease mechanisms
Wree, A., Broderick, L., Canbay, A., Hoffman, H. M., & Feldstein, A. E. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.149 · Cited by 609
Physiological functions and pathogenic potential of uric acid: A review
El Ridi, R., & Tallima, H. (2017) · Journal of Advanced Research · doi:10.1016/j.jare.2017.03.003 · Cited by 542
A Human Hepatocellular in Vitro Model to Investigate Steatosis
Gómez-Lechón, M. J., Donato, M. T., Martínez-Romero, A., Jiménez, N., Castell, J. V., & O’Connor, J.-E. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.11.004 · Cited by 576
Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Parker, H. M., Johnson, N. A., Burdon, C. A., Cohn, J. S., O’Connor, H. T., & George, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.018 · Cited by 569
Zelber-Sagi, S., Nitzan-Kaluski, D., Goldsmith, R., Webb, M., Blendis, L., Halpern, Z., & Oren, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.020 · Cited by 551
In vivo characterization of the liver fat 1H MR spectrum
Hamilton, G., Yokoo, T., Bydder, M., Cruite, I., Schroeder, M. E., Sirlin, C. B., & Middleton, M. S. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1622 · Cited by 520
Hepatocyte Death: A Clear and Present Danger
Malhi, H., Guicciardi, M. E., & Gores, G. J. (2010) · Physiological Reviews · doi:10.1152/physrev.00061.2009 · Cited by 477
Gura, K. M., Lee, S., Valim, C., Zhou, J., Kim, S., Modi, B. P., Arsenault, D. A., Strijbosch, R. A. M., Lopes, S., Duggan, C., et al. (2008) · Pediatrics · doi:10.1542/peds.2007-2248 · Cited by 455
Very long-chain n -3 fatty acids and human health: fact, fiction and the future
Calder, P. C. (2018) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117003950 · Cited by 419
CAPANNI, M., CALELLA, F., BIAGINI, M. R., GENISE, S., RAIMONDI, L., BEDOGNI, G., SVEGLIATI‐BARONI, G., SOFI, F., MILANI, S., ABBATE, R., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02885.x · Cited by 410
SpaceM reveals metabolic states of single cells
Rappez, L., Stadler, M., Triana, S., Gathungu, R. M., Ovchinnikova, K., Phapale, P., Heikenwalder, M., & Alexandrov, T. (2021) · Nature Methods · doi:10.1038/s41592-021-01198-0 · Cited by 390
Mariamenatu, A. H., & Abdu, E. M. (2021) · Journal of Lipids · doi:10.1155/2021/8848161 · Cited by 346
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Anderson, N., & Borlak, J. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 385
Parenteral Fish Oil Improves Outcomes in Patients With Parenteral Nutrition-Associated Liver Injury
Puder, M., Valim, C., Meisel, J. A., Le, H. D., de Meijer, V. E., Robinson, E. M., Zhou, J., Duggan, C., & Gura, K. M. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b36657 · Cited by 385
Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances
Lau, J. K. C., Zhang, X., & Yu, J. (2017) · The Journal of Pathology · doi:10.1002/path.4829 · Cited by 373
“Second, IR-associated hyperinsulinaemia and hyperglycaemia promote hepatic de novo lipid synthesis via upregulation of the membrane-bound transcription factor sterol regulatory element-binding protein-1c (SREBP-1c) and carbohydrate response element-binding protein (ChREBP), respectively (Figure 1) [16,17].”
BackgroundFu, Y., Wang, Y., Gao, H., Li, D., Jiang, R., Ge, L., Tong, C., & Xu, K. (2021) · Mediators of Inflammation · doi:10.1155/2021/8879227 · Cited by 343
Pettinelli, P., & Videla, L. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2129 · Cited by 351
Self-citationGura, K. M., Duggan, C. P., Collier, S. B., Jennings, R. W., Folkman, J., Bistrian, B. R., & Puder, M. (2006) · Pediatrics · doi:10.1542/peds.2005-2662 · Cited by 344
Pathophysiology of nonalcoholic steatohepatitis.
McCullough, A. J. (2006) · PubMed · doi:10.1097/01.mcg.0000168645.86658.22 · Cited by 215
Fructose: Metabolic, Hedonic, and Societal Parallels with Ethanol
Lustig, R. H. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2010.06.008 · Cited by 311
Arendt, B. M., Comelli, E. M., Ma, D. W. L., Lou, W., Teterina, A., Kim, T., Fung, S. K., Wong, D. K. H., McGilvray, I., Fischer, S. E., et al. (2015) · Hepatology · doi:10.1002/hep.27695 · Cited by 313
Vallianou, N., Christodoulatos, G. S., Karampela, I., Tsilingiris, D., Magkos, F., Stratigou, T., Kounatidis, D., & Dalamaga, M. (2021) · Biomolecules · doi:10.3390/biom12010056 · Cited by 289
Trauner, M., Arrese, M., & Wagner, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.10.007 · Cited by 291
Evolution of NAFLD and Its Management
Mundi, M. S., Velapati, S., Patel, J., Kellogg, T. A., Abu Dayyeh, B. K., & Hurt, R. T. (2020) · Nutrition in Clinical Practice · doi:10.1002/ncp.10449 · Cited by 285
Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease
Spadaro, L., Magliocco, O., Spampinato, D., Piro, S., Oliveri, C., Alagona, C., Papa, G., Rabuazzo, A. M., & Purrello, F. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.10.003 · Cited by 293
Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
Hirsova, P., Ibrabim, S. H., Gores, G. J., & Malhi, H. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r066357 · Cited by 270
Role of Insulin Resistance and Lipotoxicity in Non-Alcoholic Steatohepatitis
Cusi, K. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.009 · Cited by 266
A Model of Insulin Resistance and Nonalcoholic Steatohepatitis in Rats
Svegliati-Baroni, G., Candelaresi, C., Saccomanno, S., Ferretti, G., Bachetti, T., Marzioni, M., De Minicis, S., Nobili, L., Salzano, R., Omenetti, A., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050953 · Cited by 256
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease
Svegliati-Baroni, G., Pierantonelli, I., Torquato, P., Marinelli, R., Ferreri, C., Chatgilialoglu, C., Bartolini, D., & Galli, F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.029 · Cited by 249
Wergedahl, H., Gudbrandsen, O. A., Muna, Z., Berge, R. K., Liaset, B., Lied, E., Espe, M., & Mørk, S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.6.1320 · Cited by 246
Allard, J. P., Aghdassi, E., Mohammed, S., Raman, M., Avand, G., Arendt, B. M., Jalali, P., Kandasamy, T., Prayitno, N., Sherman, M., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.09.009 · Cited by 247
Videla, L. A., Rodrigo, R., Araya, J., & Poniachik, J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.033 · Cited by 239
Self-citationNonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
Fon Tacer, K., & Rozman, D. (2011) · Journal of Lipids · doi:10.1155/2011/783976 · Cited by 231
Pettinelli, P., del Pozo, T., Araya, J., Rodrigo, R., Araya, A. V., Smok, G., Csendes, A., Gutierrez, L., Rojas, J., Korn, O., et al. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.015 · Cited by 229
Self-citationMetabolic drivers of non-alcoholic fatty liver disease
Bence, K. K., & Birnbaum, M. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101143 · Cited by 221
Afonso, M. B., Rodrigues, P. M., Carvalho, T., Caridade, M., Borralho, P., Cortez-Pinto, H., Castro, R. E., & Rodrigues, C. M. P. (2015) · Clinical Science · doi:10.1042/cs20140732 · Cited by 221
Argo, C. K., Patrie, J. T., Lackner, C., Henry, T. D., de Lange, E. E., Weltman, A. L., Shah, N. L., Al-Osaimi, A. M., Pramoonjago, P., Jayakumar, S., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.036 · Cited by 224
Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease
Perdomo, C. M., Frühbeck, G., & Escalada, J. (2019) · Nutrients · doi:10.3390/nu11030677 · Cited by 211
Peng, K.-Y., Watt, M. J., Rensen, S., Greve, J. W., Huynh, K., Jayawardana, K. S., Meikle, P. J., & Meex, R. C. R. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m085613 · Cited by 220
Phenolic Compounds Rutin and o-Coumaric Acid Ameliorate Obesity Induced by High-Fat Diet in Rats
Hsu, C.-L., Wu, C.-H., Huang, S.-L., & Yen, G.-C. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf802715t · Cited by 212
MASTERTON, G. S., PLEVRIS, J. N., & HAYES, P. C. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04230.x · Cited by 179
Echeverría, F., Ortiz, M., Valenzuela, R., & Videla, L. A. (2016) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.10.001 · Cited by 206
Self-citationAlwayn, I. P. J., Gura, K., Nosé, V., Zausche, B., Javid, P., Garza, J., Verbesey, J., Voss, S., Ollero, M., Andersson, C., et al. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000153672.43030.75 · Cited by 204
Omega 3 – Omega 6: What is right for the liver?
El-Badry, A. M., Graf, R., & Clavien, P.-A. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.08.005 · Cited by 201
Pathogenesis of Non-alcoholic Steatohepatitis: Human Data
Edmison, J., & McCullough, A. J. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.011 · Cited by 193
Olive oil consumption and non-alcoholic fatty liver disease
Assy, N., Nassar, F., Nasser, G., & Grosovski, M. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1809 · Cited by 185
Kotronen, A., Seppänen‐Laakso, T., Westerbacka, J., Kiviluoto, T., Arola, J., Ruskeepää, A., Yki‐Järvinen, H., & Orešič, M. (2010) · Obesity · doi:10.1038/oby.2009.326 · Cited by 179
Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells.
(2010) · PubMed Central · Cited by 181
Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research
Willebrords, J., Pereira, I. V. A., Maes, M., Crespo Yanguas, S., Colle, I., Van Den Bossche, B., Da Silva, T. C., de Oliveira, C. P. M. S., Andraus, W., Alves, V. A., et al. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.05.002 · Cited by 171
Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH
Wan, X., Xu, C., Yu, C., & Li, Y. (2016) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2016/6489012 · Cited by 174
In Situ Lipidomic Analysis of Nonalcoholic Fatty Liver by Cluster TOF-SIMS Imaging
Debois, D., Bralet, M.-P., Le Naour, F., Brunelle, A., & Laprévote, O. (2009) · Analytical Chemistry · doi:10.1021/ac900045m · Cited by 168
Stearoyl‐CoA desaturase as a new drug target for obesity treatment
Dobrzyn, A., & Ntambi, J. M. (2005) · Obesity Reviews · doi:10.1111/j.1467-789x.2005.00177.x · Cited by 174
Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet
Mokhtari, Z., Gibson, D. L., & Hekmatdoost, A. (2017) · Advances in Nutrition · doi:10.3945/an.116.013151 · Cited by 166
The role of stearoyl-CoA desaturase in the control of metabolism
Dobrzyn, A., & Ntambi, J. M. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.04.011 · Cited by 167
Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis
Lee, J. J., Lambert, J. E., Hovhannisyan, Y., Ramos-Roman, M. A., Trombold, J. R., Wagner, D. A., & Parks, E. J. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.092262 · Cited by 164
Valenzuela, R., & Videla, L. A. (2011) · Food & Function · doi:10.1039/c1fo10133a · Cited by 167
Self-citationHepatic Fatty Acid Trafficking: Multiple Forks in the Road
Mashek, D. G. (2013) · Advances in Nutrition · doi:10.3945/an.113.004648 · Cited by 160
MORAVCOVÁ, A., ČERVINKOVÁ, Z., KUČERA, O., MEZERA, V., RYCHTRMOC, D., & LOTKOVÁ, H. (2015) · Physiological Research · doi:10.33549/physiolres.933224 · Cited by 165
The Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease
McCarthy, E. M., & Rinella, M. E. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jada.2011.10.007 · Cited by 162
Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD)
Syed‐Abdul, M. M. (2023) · Metabolites · doi:10.3390/metabo14010012 · Cited by 180
Johnson, N. A., Walton, D. W., Sachinwalla, T., Thompson, C. H., Smith, K., Ruell, P. A., Stannard, S. R., & George, J. (2008) · Hepatology · doi:10.1002/hep.22220 · Cited by 164
Arendt, B. M., Ma, D. W. L., Simons, B., Noureldin, S. A., Therapondos, G., Guindi, M., Sherman, M., & Allard, J. P. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0261 · Cited by 152
Vinaixa, M., Rodriguez, M. A., Rull, A., Beltrán‐Debón, R., Bladé, C., Brezmes, J., Cañellas, N., Joven, J., & Correig, X. (2010) · Journal of Proteome Research · doi:10.1021/pr901203w · Cited by 181
Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease
Videla, L. A., Rodrigo, R., Araya, J., & Poniachik, J. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.10.001 · Cited by 159
Self-citationSharma, M., Mitnala, S., Vishnubhotla, R., Mukherjee, R., Reddy, D. N., & Rao, P. N. (2015) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2015.02.002 · Cited by 158
Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease
Hannah, W. N., & Harrison, S. A. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.008 · Cited by 163
Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease
Kostrzewski, T., Cornforth, T., Snow, S. A., Ouro-Gnao, L., Rowe, C., Large, E. M., & Hughes, D. J. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i2.204 · Cited by 149
Su, H., Li, Y., Hu, D., Xie, L., Ke, H., Zheng, X., & Chen, W. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.08.024 · Cited by 158
Videla, L. A., Hernández‐Rodas, M. C., Metherel, A. H., & Valenzuela, R. (2022) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2022.102441 · Cited by 157
Self-citationRoumans, K. H. M., Lindeboom, L., Veeraiah, P., Remie, C. M. E., Phielix, E., Havekes, B., Bruls, Y. M. H., Brouwers, M. C. G. J., Ståhlman, M., Alssema, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15684-0 · Cited by 138
Lipidomics in non-alcoholic fatty liver disease
Kartsoli, S., Kostara, C. E., Tsimihodimos, V., Bairaktari, E. T., & Christodoulou, D. K. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i8.436 · Cited by 163
Role of diet and lifestyle changes in nonalcoholic fatty liver disease.
Nseir, W., Hellou, E., & Assy, N. (2014) · PubMed · doi:10.3748/wjg.v20.i28.9338 · Cited by 139
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms
Videla, L. A. (2009) · World Journal of Hepatology · doi:10.4254/wjh.v1.i1.72 · Cited by 144
Self-citationEffect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease
Chavez-Tapia, N. C., Rosso, N., & Tiribelli, C. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-20 · Cited by 137
Ucar, F., Sezer, S., Erdogan, S., Akyol, S., Armutcu, F., & Akyol, O. (2013) · Redox Report · doi:10.1179/1351000213y.0000000050 · Cited by 143
Valenzuela, R., Illesca, P., Echeverría, F., Espinosa, A., Rincón‐Cervera, M. Á., Ortíz, M., Hernández‐Rodas, M. C., Valenzuela, A., & Videla, L. A. (2017) · Food & Function · doi:10.1039/c7fo00090a · Cited by 150
Self-citationRole of bioactive fatty acids in nonalcoholic fatty liver disease
Juárez-Hernández, E., Chávez-Tapia, N. C., Uribe, M., & Barbero-Becerra, V. J. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0191-8 · Cited by 147
Tie, F., Ding, J. J., Hu, N., Dong, Q. Z., Chen, Z., & Wang, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168847 · Cited by 142
Ruby, M. A., Massart, J., Hunerdosse, D. M., Schönke, M., Correia, J. C., Louie, S. M., Ruas, J. L., Näslund, E. B., Nomura, D. K., & Zierath, J. R. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.070 · Cited by 141
López-Vicario, C., González-Périz, A., Rius, B., Morán-Salvador, E., García-Alonso, V., Lozano, J. J., Bataller, R., Cofán, M., Kang, J. X., Arroyo, V., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-303179 · Cited by 131
Hernández‐Rodas, M. C., Valenzuela, R., Echeverría, F., Rincón‐Cervera, M. Á., Espinosa, A., Illesca, P., Muñoz, P., Corbari, A., Romero, N., Gonzalez‐Mañán, D., et al. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700479 · Cited by 135
Self-citationRafiei, H., Omidian, K., & Bandy, B. (2019) · Nutrients · doi:10.3390/nu11030541 · Cited by 137
Oxidative Stress and Redox Signaling in the Pathophysiology of Liver Diseases
Mooli, R. G. R., Mukhi, D., & Ramakrishnan, S. K. (2022) · Comprehensive physiology · doi:10.1002/cphy.c200021 · Cited by 152
Yan, J.-H., Guan, B.-J., Gao, H.-Y., & Peng, X.-E. (2018) · Medicine · doi:10.1097/md.0000000000012271 · Cited by 130
Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease
Hernandez-Rodas, M., Valenzuela, R., & Videla, L. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025168 · Cited by 130
Self-citationLifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease
Hannah, W. N., & Harrison, S. A. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4153-y · Cited by 139
Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Lu, W., Li, S., Li, J., Wang, J., Zhang, R., Zhou, Y., Yin, Q., Zheng, Y., Wang, F., Xia, Y., et al. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/1459790 · Cited by 123
Metadata
- Authors
- ARAYA, J., RODRIGO, R., VIDELA, L. A., THIELEMANN, L., ORELLANA, M., PETTINELLI, P., & PONIACHIK, J.
- Affiliations
- Departamento de Nutrición, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Casilla 70058, Santiago 7, Santiago, Chile
- University of Chile (CL)
- Programa de Farmacología Molecular y Clínica, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Casilla 70058, Santiago 7, Santiago, Chile
- Servicio de Gastroenterología, Hospital Clínico de la Universidad de Chile, Casilla 70058, Santiago 7, Santiago, Chile
- Corresponding author
- PETTINELLI, Paulina
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2004-06-01
- Volume
- 106
- Issue
- 6
- Pages
- 635-643
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2072721395
- Cited by
- 700
- References
- 46
- Citations by year
- 2026: 12 · 2025: 27 · 2024: 25 · 2023: 26 · 2022: 31 · 2021: 42 · 2020: 56 · 2019: 43 · 2018: 34 · 2017: 46 · 2016: 41 · 2015: 41 · 2014: 39 · 2013: 37 · 2012: 40
- FWCI
- 12.00
- Type
- journal article
- Language
- en
- Open access
- green
- americanae.aecid.es
- Licence
- other-oa
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- non-alcoholic fatty liver disease, hepatic steatosis, long-chain polyunsaturated fatty acids, n-6/n-3 ratio, hepatic triglycerides, hepatic phospholipids, adipose tissue fatty acids, trans fatty acids, lipid peroxidation, oxidative stress, protein carbonylation, malondialdehyde, fatty acid desaturation
- MeSH terms
- Adipose Tissue, Adult, Fatty Acids, Unsaturated, Fatty Liver, Humans, Lipids, Liver, Middle Aged, Phospholipids, Triglycerides, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.